Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adjuvant use in stage III colon cancer either alone or as part of combination chemotherapy.
LAMPGEN ANALYSIS
Why it matters
The Project Renewal decision updates the postoperative indication to include combination treatment.
What research teams should watch
Document surgical stage and identify the full regimen rather than reporting all postoperative capecitabine as monotherapy.
PRIMARY RECORDS